FDA warns of potentially fatal skin reaction with ziprasidone

The Food and Drug Administration is warning that the atypical antipsychotic ziprasidone (Geodon) may be associated with a rare but potentially fatal skin reaction. The agency issued the communication on Dec. 11, saying that it had...googletag.display('div-gpt-ad-cta');
Source: Skin and Allergy News - Category: Dermatology Tags: CPN FDA & CDC CPN News CPN Psychotic Disorders EM FDA and CDC EM News EM Dermatology FPN FDA Source Type: news